Pliant Therapeutics adopts limited-duration poison pill; rights expire March 11, 2026

PLIANT THERAPEUTICS, INC.

Board adopted rights agreement on March 12, 2025; dividend of one right per share to holders of record March 25, 2025.
Rights become exercisable at $12.64/right if a person acquires 10% (20% for passive investors) of stock without approval.
Upon trigger, holders (excluding acquiring person) can buy shares at 50% discount; rights expire March 11, 2026.
Existing holders above thresholds are grandfathered but cannot increase ownership without losing grandfathered status.
Board may redeem rights at $0.001 each or exchange for common stock prior to trigger.

item 1.01 item 3.03 item 5.03 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

PLIANT THERAPEUTICS, INC.: Adopted Certificate of Designation for Series A Junior Participating Preferred Stock in connection with stockholder rights agreement (effective 2025-03-13).

Change: charter amendment
Effective: 2025-03-13

Exact text from the filing

In connection with the adoption of the Rights Agreement described in Item 3.03 of this Current Report, the Board approved a Certificate of Designation of Series A Junior Participating Preferred Stock, which designates the rights, preferences and privileges of 300,000 shares of a series of the Company’s preferred stock, par value $0.0001 per share, designated as Series A Junior Participating Preferred Stock.

View on SEC.gov

74 governance changes filed in the last 30 days. Browse all governance changes →

PLIANT THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001193125-25-053541

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.